Paper Details

  1. Home
  2. Paper Details

Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial.

Author: AbeTakayuki, HiranoJinichi, KashimaHaruo, MimuraMasaru, NakajimaShinichiro, SuzukiTakefumi, TakeuchiHiroyoshi, UchidaHiroyuki, WatanabeKoichiro, YagihashiTatsuhiko

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

In a study of 41 patients with major depressive disorder (MDD) who failed to respond to sertraline in the first 2 weeks of treatment, those who switched to paroxetine had a higher response rate (75%) than those who continued sertraline (19%). This suggests that early switching of antidepressants may be a beneficial strategy for patients with MDD who do not respond quickly to initial treatment.
Paper Details　
Original Abstract of the Article :
RATIONALE: Treatment guidelines for major depressive disorder (MDD) recommend a continuous use of antidepressants for several weeks, while recent meta-analyses indicate that antidepressant efficacy starts to appear within 2 weeks and early treatment nonresponse is a predictor of subsequent nonrespon...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.pnpbp.2011.08.008

データ提供：米国国立医学図書館（NLM）

Early Antidepressant Switching: A Potential Game Changer

This study delves into the world of [Depression treatment], a field where we strive to [Improve outcomes for patients with major depressive disorder]. The research employs [A randomized open-label trial] to investigate [The effectiveness of switching antidepressants in early nonresponders]. The authors uncover [Switching antidepressants was associated with higher response and remission rates] and suggest that [Early switching may be a more effective treatment strategy for depression]. This study is like a refreshing oasis in the desert of [Depression research], offering a new perspective on [Treatment optimization].

A New Approach to Depression Treatment

The study reveals that [Patients with depression who don't respond to the initial antidepressant within two weeks may benefit from switching to a different medication]. This is a significant finding because it suggests that [Early intervention is crucial in depression treatment]. It's like knowing where to find water in the desert – early detection and intervention can make all the difference.

Early Intervention: Key to Positive Outcomes

This study highlights the importance of [Early intervention] in [Depression treatment]. Just like a traveler in the desert needs to find water quickly to avoid dehydration, patients with depression need to receive effective treatment as soon as possible. This research suggests that [Switching antidepressants early] may lead to [Improved outcomes] for [Patients with depression].

Dr.Camel's Conclusion

This research provides compelling evidence that [Early switching] may be a more effective treatment strategy for [Depression] than [Continuing the initial antidepressant]. It suggests that [Clinicians] should be prepared to [Switch medications] if patients don't respond to the initial treatment within a timely manner.

Date :
  1. Date Completed 2014-06-09
  2. Date Revised 2022-03-11
Further Info :

Pubmed ID

21889560

DOI: Digital Object Identifier

10.1016/j.pnpbp.2011.08.008

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.